[1]
“Real-World Tralokinumab Use in Dupilumab-Experienced Patients: A Retrospective Multi-Center Case Series”, J of Skin, vol. 8, no. 1, p. s321, Jan. 2024, doi: 10.25251/skin.8.supp.321.